COVID-19 Rapid Antibody Detection Kit

The COVID-19 IgG/IgM (Whole Blood/Serum/Plasma) Rapid Test Device utilizes lateral flow technology that is used for the qualitative, differential detection of both anti-SARS-CoV-2 IgM and IgG antibodies. In general, antibodies can be detected 1-3 weeks after infection. This test is intended to screen patients for COVID-19. Combining RNA and Antibody tests can significantly raise the sensitivity for detecting COVID-19 in infected individuals.


How Does the Test Work?

The Rapid test is a qualitative detection of IgM and IgG antibodies that bind to the virus that causes COVID-19. With a simple finger blood specimen, it will provide results in minutes. The presence of antibody Immunoglobulin G and Immunoglobulin M (IgG and IgM) proteins specific for SARS-Cov-2 IgG and IgM antibodies are indicated by a visible line in the specific region indicated on the device.

COVID-19 Rapid Antibody Detection Kit

    • Fast Results in 15 minutes • Highly accurate (IgM and IgG combined sensitivity and specificity is 90.6% and 99-2% respectively. Total accordance rate equals 95.3%. 92% sensitivity

    • NO laboratory equipment required, intuitive visual interpretation

    • NO specialized training required, easy-to-use

    • Provides actionable information to all patients to help determine if a COVID-19 viral PCR test is needed

    • Provides insightful information for when it is safe for individuals to go back to work and resume normal activities of daily life

    • Test kits can be stored and used at room temperature

    • Antibody testing is improved over nasopharyngeal swab testing by the fact that antibodies are more uniformly present in blood sampling